Search results for: 'NMR 3 mm'
-
-
-
-
-
-
-
-
-
-
-
13C, 15N Microcrystalline GB1
CCN10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N Microcrystalline GB1
CCN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N Microcrystalline GB1
CCN10033P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P5
3 - 6 weeks• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N, D Calbindin in Solution
CCND10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Calbindin in Solution
CCND10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Calbindin in Solution
CCND10014P5
3 - 6 weeks• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
-
-
-
-
13C, 15N, D Microcrystalline GB1
CCND10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Microcrystalline GB1
CCND10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Microcrystalline GB1
CCND10033P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D GB1 in Solution
CCND10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D GB1 in Solution
CCND10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D GB1 in Solution
CCND10034P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D MBP in Solution
CCND10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D -
13C, 15N, D MBP in Solution
CCND10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D -
13C, 15N, D MBP in Solution
CCND10044P5
3 - 6 weeks• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D -
-
-
150 mL Suprasil Large Volume Dewar Flask
WG-850-B-Q$1,428.202-4 weeksFor Bruker and Jeol instruments -
150 mL Suprasil Nitrogen Dewar Flask
WG-850-Q$1,428.202-4 weeksFor Micro-Now, Radio-Pan and Agilent instruments -
150 mL Suprasil Offset Nitrogen Dewar Flask
WG-853-B-Q$1,454.602-4 weeksFor Bruker and Jeol instruments -
Testosterone-2,3,4-13C3 Solution
CC3851P
2 - 4 weeks• 0.1 mg/mL In 1,2-Dimethoxyethane
• 99% 13C, 98% CP -
Dihydrotestosterone-2,3,4-13C3 Solution
CC3852P
2 - 4 weeks• 0.1 mg/mL In 1,2-Dimethoxyethane
• 99% 13C, 98% CP -
-
-
-
-
-
-
-
-
-
-
Dehydroepiandrosterone-2,2,3,4,4,6-d6
CD236P
2 - 4 weeks• Sulfate Sodium Salt
• 85% D (Min. 5D/Molecule) -
-
-
-
-
-
-
-
-
10mm Symmetrical Microtube Matched with DMSO
DMS-010
2 - 4 weeks• For Bruker and Jeol probe
• 10mm Symmetrical Microtube
• Matched with DMSO -
Precision Thin Wall Quartz Sleeve, 5.5 x 6.0 x 58.6 mm
NE-295-5A$111.504 - 6 weeksFor Bruker Late Model Probes -
Precision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 54.5 mm
NE-295-5B$157.504 - 6 weeksFor Bruker Dual Flow Probes -
Precision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 64 mm
NE-295-V-5$157.504 - 6 weeksFor Varian Probes -
-
Potassium Palmitate-1,3,5,7,9-13C5
CC2448P
2 - 4 weeks• Sterility and Pyrogenicity Tested
• 99% 13C, 98% CP -
-
-
-
7-Methylxanthine-2,4,5,6-13C4,1,3-15N2
CCN6351P
2 - 4 weeks• Partial 15N Labeling At N9
• 99% 13C, 98% 15N (Based On 15N2), 98% CP -
-
-
-
-
n-dodecyl b-D-maltopyranoside-d25 (DDM-d25)
CD5066P025$2,860.004 - 8 weeks• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
-
-
-
-
-
-
D-Glucose-13C6-1,2,3,4,5,6,6-d7
CCD860P1
to be confirmedCAS number: 201417-01-8
HO13CD2(O)13CD13CD(OH)13CD(OH)13CD(OH)13CDOH -
D-Glucose-13C6-1,2,3,4,5,6,6-d7
CCD860P10
to be confirmedCAS number: 201417-01-8
HO*CD2(O)13CD13CD(OH)13CD(OH)13CD(OH)13CDOH -
-
W Band Suprasil EPR Tube both ends open, 40 mm, Pack of 10
WG-213ST9S$209.902-4 weeks• For photochemistry studies
• Suprasil®
• Cutoff wavelength: 190 nm -
W Band Suprasil EPR Tube one end sealed, 40 mm, Pack of 10
WG-213ST9S-RB$261.502-4 weeks• For photochemistry studies
• Suprasil®
• Cutoff wavelength: 190 nm -
Q Band Suprasil EPR Tube both ends open, 100 mm, Pack of 10
WG-222T$253.502-4 weeks• For photochemistry studies
• Suprasil®
• Cutoff wavelength: 190 nm -
Q Band Suprasil EPR Tube one end sealed, 100 mm, Pack of 10
WG-222T-RB$294.802-4 weeks• For photochemistry studies
• Suprasil®
• Cutoff wavelength: 190 nm -
Q Band CFQ EPR Tube one end sealed, 100 mm, Pack of 10
WG-221T-RB$207.102-4 weeks• For photochemistry studies
• Cleared Fused QuartzQ
• Cutoff wavelength: 190 nm -
-
-
-
-
-
-
-
-
-
-
-
-
-
unlabeled fMLF
C10073P100
3 - 6 weeks• 100 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
unlabeled fMLF
C10073P50
3 - 6 weeks• 50 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
unlabeled fMLF
C10073P500
3 - 6 weeks• 500 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
13C fMLF
CC10073P10
3 - 6 weeks• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C
• Crystallized -
13C fMLF
CC10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C
• Crystallized -
13C fMLF
CC10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C
• Crystallized -
15N fMLF
CN10073P10
3 - 6 weeks• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 15N
• Crystallized -
15N fMLF
CN10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 15N
• Crystallized -
15N fMLF
CN10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 15N
• Crystallized -
13C, 15N fMLF
CCN10073P10
3 - 6 weeks• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N fMLF
CCN10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N fMLF
CCN10073P5
3 - 6 weeks• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N fMLF
CCN10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N, D fMLF
CCND10073P10
3 - 6 weeks• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -
13C, 15N, D fMLF
CCND10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -
13C, 15N, D fMLF
CCND10073P5
3 - 6 weeks• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -
13C, 15N, D fMLF
CCND10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -